Global Pharmacogenomics Technology (Theranostics and CDx) Market Research Report 2024(Status and Outlook)

Global Pharmacogenomics Technology (Theranostics and CDx) Market Research Report 2024(Status and Outlook)



Report Overview:

The Global Pharmacogenomics Technology (Theranostics and CDx) Market Size was estimated at USD 4221.19 million in 2023 and is projected to reach USD 9612.04 million by 2029, exhibiting a CAGR of 14.70% during the forecast period.

This report provides a deep insight into the global Pharmacogenomics Technology (Theranostics and CDx) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmacogenomics Technology (Theranostics and CDx) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmacogenomics Technology (Theranostics and CDx) market in any manner.

Global Pharmacogenomics Technology (Theranostics and CDx) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Illumina

Roche

Agilent

Abbott

Thermofisher

Qiagen

Guardant Health

MGI Tech Co., Ltd.

Amoydx Biology

Genomics

Market Segmentation (by Type)

Instrument

Reagents and Consumables

Others

Market Segmentation (by Application)

Tumor

Diabetes

Mental Diseases

Cardiovascular Diseases

Others

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Pharmacogenomics Technology (Theranostics and CDx) Market
  • Overview of the regional outlook of the Pharmacogenomics Technology (Theranostics and CDx) Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacogenomics Technology (Theranostics and CDx) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pharmacogenomics Technology (Theranostics and CDx)
1.2 Key Market Segments
1.2.1 Pharmacogenomics Technology (Theranostics and CDx) Segment by Type
1.2.2 Pharmacogenomics Technology (Theranostics and CDx) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pharmacogenomics Technology (Theranostics and CDx) Market Overview
2.1 Global Market Overview
2.1.1 Global Pharmacogenomics Technology (Theranostics and CDx) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharmacogenomics Technology (Theranostics and CDx) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pharmacogenomics Technology (Theranostics and CDx) Market Competitive Landscape
3.1 Global Pharmacogenomics Technology (Theranostics and CDx) Sales by Manufacturers (2019-2024)
3.2 Global Pharmacogenomics Technology (Theranostics and CDx) Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharmacogenomics Technology (Theranostics and CDx) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmacogenomics Technology (Theranostics and CDx) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharmacogenomics Technology (Theranostics and CDx) Sales Sites, Area Served, Product Type
3.6 Pharmacogenomics Technology (Theranostics and CDx) Market Competitive Situation and Trends
3.6.1 Pharmacogenomics Technology (Theranostics and CDx) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmacogenomics Technology (Theranostics and CDx) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pharmacogenomics Technology (Theranostics and CDx) Industry Chain Analysis
4.1 Pharmacogenomics Technology (Theranostics and CDx) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pharmacogenomics Technology (Theranostics and CDx) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pharmacogenomics Technology (Theranostics and CDx) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacogenomics Technology (Theranostics and CDx) Sales Market Share by Type (2019-2024)
6.3 Global Pharmacogenomics Technology (Theranostics and CDx) Market Size Market Share by Type (2019-2024)
6.4 Global Pharmacogenomics Technology (Theranostics and CDx) Price by Type (2019-2024)
7 Pharmacogenomics Technology (Theranostics and CDx) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacogenomics Technology (Theranostics and CDx) Market Sales by Application (2019-2024)
7.3 Global Pharmacogenomics Technology (Theranostics and CDx) Market Size (M USD) by Application (2019-2024)
7.4 Global Pharmacogenomics Technology (Theranostics and CDx) Sales Growth Rate by Application (2019-2024)
8 Pharmacogenomics Technology (Theranostics and CDx) Market Segmentation by Region
8.1 Global Pharmacogenomics Technology (Theranostics and CDx) Sales by Region
8.1.1 Global Pharmacogenomics Technology (Theranostics and CDx) Sales by Region
8.1.2 Global Pharmacogenomics Technology (Theranostics and CDx) Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmacogenomics Technology (Theranostics and CDx) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmacogenomics Technology (Theranostics and CDx) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmacogenomics Technology (Theranostics and CDx) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmacogenomics Technology (Theranostics and CDx) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmacogenomics Technology (Theranostics and CDx) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Illumina
9.1.1 Illumina Pharmacogenomics Technology (Theranostics and CDx) Basic Information
9.1.2 Illumina Pharmacogenomics Technology (Theranostics and CDx) Product Overview
9.1.3 Illumina Pharmacogenomics Technology (Theranostics and CDx) Product Market Performance
9.1.4 Illumina Business Overview
9.1.5 Illumina Pharmacogenomics Technology (Theranostics and CDx) SWOT Analysis
9.1.6 Illumina Recent Developments
9.2 Roche
9.2.1 Roche Pharmacogenomics Technology (Theranostics and CDx) Basic Information
9.2.2 Roche Pharmacogenomics Technology (Theranostics and CDx) Product Overview
9.2.3 Roche Pharmacogenomics Technology (Theranostics and CDx) Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche Pharmacogenomics Technology (Theranostics and CDx) SWOT Analysis
9.2.6 Roche Recent Developments
9.3 Agilent
9.3.1 Agilent Pharmacogenomics Technology (Theranostics and CDx) Basic Information
9.3.2 Agilent Pharmacogenomics Technology (Theranostics and CDx) Product Overview
9.3.3 Agilent Pharmacogenomics Technology (Theranostics and CDx) Product Market Performance
9.3.4 Agilent Pharmacogenomics Technology (Theranostics and CDx) SWOT Analysis
9.3.5 Agilent Business Overview
9.3.6 Agilent Recent Developments
9.4 Abbott
9.4.1 Abbott Pharmacogenomics Technology (Theranostics and CDx) Basic Information
9.4.2 Abbott Pharmacogenomics Technology (Theranostics and CDx) Product Overview
9.4.3 Abbott Pharmacogenomics Technology (Theranostics and CDx) Product Market Performance
9.4.4 Abbott Business Overview
9.4.5 Abbott Recent Developments
9.5 Thermofisher
9.5.1 Thermofisher Pharmacogenomics Technology (Theranostics and CDx) Basic Information
9.5.2 Thermofisher Pharmacogenomics Technology (Theranostics and CDx) Product Overview
9.5.3 Thermofisher Pharmacogenomics Technology (Theranostics and CDx) Product Market Performance
9.5.4 Thermofisher Business Overview
9.5.5 Thermofisher Recent Developments
9.6 Qiagen
9.6.1 Qiagen Pharmacogenomics Technology (Theranostics and CDx) Basic Information
9.6.2 Qiagen Pharmacogenomics Technology (Theranostics and CDx) Product Overview
9.6.3 Qiagen Pharmacogenomics Technology (Theranostics and CDx) Product Market Performance
9.6.4 Qiagen Business Overview
9.6.5 Qiagen Recent Developments
9.7 Guardant Health
9.7.1 Guardant Health Pharmacogenomics Technology (Theranostics and CDx) Basic Information
9.7.2 Guardant Health Pharmacogenomics Technology (Theranostics and CDx) Product Overview
9.7.3 Guardant Health Pharmacogenomics Technology (Theranostics and CDx) Product Market Performance
9.7.4 Guardant Health Business Overview
9.7.5 Guardant Health Recent Developments
9.8 MGI Tech Co., Ltd.
9.8.1 MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics and CDx) Basic Information
9.8.2 MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics and CDx) Product Overview
9.8.3 MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics and CDx) Product Market Performance
9.8.4 MGI Tech Co., Ltd. Business Overview
9.8.5 MGI Tech Co., Ltd. Recent Developments
9.9 Amoydx Biology
9.9.1 Amoydx Biology Pharmacogenomics Technology (Theranostics and CDx) Basic Information
9.9.2 Amoydx Biology Pharmacogenomics Technology (Theranostics and CDx) Product Overview
9.9.3 Amoydx Biology Pharmacogenomics Technology (Theranostics and CDx) Product Market Performance
9.9.4 Amoydx Biology Business Overview
9.9.5 Amoydx Biology Recent Developments
9.10 Genomics
9.10.1 Genomics Pharmacogenomics Technology (Theranostics and CDx) Basic Information
9.10.2 Genomics Pharmacogenomics Technology (Theranostics and CDx) Product Overview
9.10.3 Genomics Pharmacogenomics Technology (Theranostics and CDx) Product Market Performance
9.10.4 Genomics Business Overview
9.10.5 Genomics Recent Developments
10 Pharmacogenomics Technology (Theranostics and CDx) Market Forecast by Region
10.1 Global Pharmacogenomics Technology (Theranostics and CDx) Market Size Forecast
10.2 Global Pharmacogenomics Technology (Theranostics and CDx) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharmacogenomics Technology (Theranostics and CDx) Market Size Forecast by Country
10.2.3 Asia Pacific Pharmacogenomics Technology (Theranostics and CDx) Market Size Forecast by Region
10.2.4 South America Pharmacogenomics Technology (Theranostics and CDx) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharmacogenomics Technology (Theranostics and CDx) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Pharmacogenomics Technology (Theranostics and CDx) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharmacogenomics Technology (Theranostics and CDx) by Type (2025-2030)
11.1.2 Global Pharmacogenomics Technology (Theranostics and CDx) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharmacogenomics Technology (Theranostics and CDx) by Type (2025-2030)
11.2 Global Pharmacogenomics Technology (Theranostics and CDx) Market Forecast by Application (2025-2030)
11.2.1 Global Pharmacogenomics Technology (Theranostics and CDx) Sales (K Units) Forecast by Application
11.2.2 Global Pharmacogenomics Technology (Theranostics and CDx) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings